WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (62)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzjohn, S. M.
Right arrow Articles by Seabrook, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzjohn, S. M.
Right arrow Articles by Seabrook, G. R.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 2001, 21(13):4691-4698

Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein

Stephen M. Fitzjohn1, Robin A. Morton1, 2, 3, Frederick Kuenzi1, 3, Thomas W. Rosahl3, Mark Shearman3, Huw Lewis3, David Smith3, David S. Reynolds3, Ceri H. Davies2, Graham L. Collingridge1, and Guy R. Seabrook3

1 Medical Research Council Centre for Synaptic Plasticity, Department of Anatomy, University of Bristol, Bristol, BS8 1TD, United Kingdom, 2 Department of Pharmacology, University of Edinburgh, Edinburgh, EH8 9JZ, United Kingdom, and 3 Merck Sharp and Dohme Research Laboratories, The Neuroscience Research Centre, Harlow, Essex, CM20 2QR, United Kingdom

We have studied synaptic function in a transgenic mouse strain relevant to Alzheimer's disease (AD), overexpressing the 695 amino acid isoform of human amyloid precursor protein with K670N and M671L mutations (APP695SWE mice), which is associated with early-onset familial AD. Aged-transgenic mice had substantially elevated levels of Abeta (up to 22 µmol/gm) and displayed characteristic Abeta plaques. Hippocampal slices from 12-month-old APP695SWE transgenic animals displayed reduced levels of synaptic transmission in the CA1 region when compared with wild-type littermate controls. Inclusion of the ionotropic glutamate receptor antagonist kynurenate during preparation of brain slices abolished this deficit. At 18 months of age, a selective deficit in basal synaptic transmission was observed in the CA1 region despite treatment with kynurenate. Paired-pulse facilitation and long-term potentiation (LTP) were normal in APP695SWE transgenic mice at both 12 and 18 months of age. Thus, although aged APP695SWE transgenic mice have greatly elevated levels of Abeta protein, increased numbers of plaques, and reduced basal synaptic transmission, LTP can still be induced and expressed normally. We conclude that increased susceptibility to excitotoxicity rather than a specific effect on LTP is the primary cause of cognitive deficits in APP695SWE mice.

Key words: Alzheimer's disease; synaptic plasticity; LTP; hippocampus; APP; transgenic


Copyright © 2001 Society for Neuroscience  0270-6474/01/21134691-08$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Rohe, A.-S. Carlo, H. Breyhan, A. Sporbert, D. Militz, V. Schmidt, C. Wozny, A. Harmeier, B. Erdmann, K. R. Bales, et al.
Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis
J. Biol. Chem., May 23, 2008; 283(21): 14826 - 14834.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
G. R Seabrook, W. J. Ray, M. Shearman, and M. Hutton
BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Mol. Interv., October 1, 2007; 7(5): 261 - 270.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ma, S. Lesne, L. Kotilinek, J. V. Steidl-Nichols, M. Sherman, L. Younkin, S. Younkin, C. Forster, N. Sergeant, A. Delacourte, et al.
Involvement of -site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity
PNAS, May 8, 2007; 104(19): 8167 - 8172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Priller, I. Dewachter, N. Vassallo, S. Paluch, C. Pace, H. A. Kretzschmar, F. Van Leuven, and J. Herms
Mutant Presenilin 1 Alters Synaptic Transmission in Cultured Hippocampal Neurons
J. Biol. Chem., January 12, 2007; 282(2): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. J. Saganich, B. E. Schroeder, V. Galvan, D. E. Bredesen, E. H. Koo, and S. F. Heinemann
Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP
J. Neurosci., December 27, 2006; 26(52): 13428 - 13436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Kelly and A. Ferreira
beta-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons
J. Biol. Chem., September 22, 2006; 281(38): 28079 - 28089.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. H. Chang, M. J. Savage, D. G. Flood, J. M. Thomas, R. B. Levy, V. Mahadomrongkul, T. Shirao, C. Aoki, and P. T. Huerta
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
PNAS, February 28, 2006; 103(9): 3410 - 3415.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Saura, G. Chen, S. Malkani, S.-Y. Choi, R. H. Takahashi, D. Zhang, G. K. Gouras, A. Kirkwood, R. G. M. Morris, and J. Shen
Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., July 20, 2005; 25(29): 6755 - 6764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Terwel, R. Lasrado, J. Snauwaert, E. Vandeweert, C. Van Haesendonck, P. Borghgraef, and F. Van Leuven
Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice
J. Biol. Chem., February 4, 2005; 280(5): 3963 - 3973.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Minkeviciene, P. Banerjee, and H. Tanila
Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 677 - 682.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
S. Middei, R. Geracitano, A. Caprioli, N. Mercuri, and M. Ammassari-Teule
Preserved Fronto-Striatal Plasticity and Enhanced Procedural Learning in a Transgenic Mouse Model of Alzheimer's Disease Overexpressing Mutant hAPPswe
Learn. Mem., July 1, 2004; 11(4): 447 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. W. S. Law, A. Y. W. Lee, M. Sun, A. G. Nikonenko, S. K. Chung, A. Dityatev, M. Schachner, and F. Morellini
Decreased Anxiety, Altered Place Learning, and Increased CA1 Basal Excitatory Synaptic Transmission in Mice with Conditional Ablation of the Neural Cell Adhesion Molecule L1
J. Neurosci., November 12, 2003; 23(32): 10419 - 10432.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. G. Richards, G. A. Higgins, A.-M. Ouagazzal, L. Ozmen, J. N. C. Kew, B. Bohrmann, P. Malherbe, M. Brockhaus, H. Loetscher, C. Czech, et al.
PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation
J. Neurosci., October 1, 2003; 23(26): 8989 - 9003.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Dickey, J. F. Loring, J. Montgomery, M. N. Gordon, P. S. Eastman, and D. Morgan
Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice
J. Neurosci., June 15, 2003; 23(12): 5219 - 5226.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Redwine, B. Kosofsky, R. E. Jacobs, D. Games, J. F. Reilly, J. H. Morrison, W. G. Young, and F. E. Bloom
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
PNAS, February 4, 2003; 100(3): 1381 - 1386.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. J. Selkoe
Alzheimer's Disease Is a Synaptic Failure
Science, October 25, 2002; 298(5594): 789 - 791.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
K. A. Corcoran, Y. Lu, R. S. Turner, and S. Maren
Overexpression of hAPPswe Impairs Rewarded Alternation and Contextual Fear Conditioning in a Transgenic Mouse Model of Alzheimer's Disease
Learn. Mem., September 1, 2002; 9(5): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ikegaya, S. Matsuura, S. Ueno, A. Baba, M. K. Yamada, N. Nishiyama, and N. Matsuki
beta -Amyloid Enhances Glial Glutamate Uptake Activity and Attenuates Synaptic Efficacy
J. Biol. Chem., August 23, 2002; 277(35): 32180 - 32186.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
K. H. Ashe
Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease
Learn. Mem., November 1, 2001; 8(6): 301 - 308.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-